BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19435811)

  • 1. A key role for early growth response-1 and nuclear factor-kappaB in mediating and maintaining GRO/CXCR2 proliferative signaling in esophageal cancer.
    Wang B; Khachigian LM; Esau L; Birrer MJ; Zhao X; Parker MI; Hendricks DT
    Mol Cancer Res; 2009 May; 7(5):755-64. PubMed ID: 19435811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer.
    Wang B; Hendricks DT; Wamunyokoli F; Parker MI
    Cancer Res; 2006 Mar; 66(6):3071-7. PubMed ID: 16540656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signaling.
    Dong YL; Kabir SM; Lee ES; Son DS
    PLoS One; 2013; 8(12):e83789. PubMed ID: 24376747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone and calcitriol attenuate inflammatory cytokines CXCL1 and CXCL2 in ovarian and endometrial cancer cells.
    Kavandi L; Collier MA; Nguyen H; Syed V
    J Cell Biochem; 2012 Oct; 113(10):3143-52. PubMed ID: 22615136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear factor-kB signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA.
    Tian F; Zang WD; Hou WH; Liu HT; Xue LX
    Acta Biochim Biophys Sin (Shanghai); 2006 May; 38(5):318-26. PubMed ID: 16680372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Egr-1 by siRNA in prostate carcinoma cell lines is associated with decreased expression of AP-1 and NF-κB.
    Parra E; Ferreira J; Saenz L
    Int J Mol Med; 2011 Nov; 28(5):847-53. PubMed ID: 21743958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of the growth-regulated oncogene α gene by early growth response protein-1 in response to tumor necrosis factor α stimulation.
    Shin SY; Lee JM; Lim Y; Lee YH
    Biochim Biophys Acta; 2013 Oct; 1829(10):1066-74. PubMed ID: 23872552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis.
    Yang G; Rosen DG; Liu G; Yang F; Guo X; Xiao X; Xue F; Mercado-Uribe I; Huang J; Lin SH; Mills GB; Liu J
    Clin Cancer Res; 2010 Aug; 16(15):3875-86. PubMed ID: 20505188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GROβ and its downstream effector EGR1 regulate cisplatin-induced apoptosis in WHCO1 cells.
    Dong Q; Zhang J; Hendricks DT; Zhao X
    Oncol Rep; 2011 Apr; 25(4):1031-7. PubMed ID: 21271225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A small interfering RNA targeting NF-κB p65 alone or combined with 5-FU inhibits growth of esophageal squamous cell carcinoma in nude mice.
    Tian F; Fan T; Jiang Y; Zhang X; Wang X
    Pathol Res Pract; 2012 Jan; 208(1):32-8. PubMed ID: 22186294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice.
    Tian F; Zhang C; Tian W; Jiang Y; Zhang X
    Oncol Rep; 2012 Jul; 28(1):232-40. PubMed ID: 22552693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism.
    Gupta V; Yeo G; Kawakubo H; Rangnekar V; Ramaswamy P; Hayashida T; MacLaughlin DT; Donahoe PK; Maheswaran S
    Cancer Res; 2007 Mar; 67(6):2747-56. PubMed ID: 17363596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.
    Zhao Y; Wei L; Shao M; Huang X; Chang J; Zheng J; Chu J; Cui Q; Peng L; Luo Y; Tan W; Tan W; Lin D; Wu C
    Gastroenterology; 2017 Nov; 153(5):1304-1319.e5. PubMed ID: 28780075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levo-corydalmine alleviates vincristine-induced neuropathic pain in mice by inhibiting an NF-kappa B-dependent CXCL1/CXCR2 signaling pathway.
    Zhou L; Hu Y; Li C; Yan Y; Ao L; Yu B; Fang W; Liu J; Li Y
    Neuropharmacology; 2018 Jun; 135():34-47. PubMed ID: 29518397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer.
    Zhang H; Ye YL; Li MX; Ye SB; Huang WR; Cai TT; He J; Peng JY; Duan TH; Cui J; Zhang XS; Zhou FJ; Wang RF; Li J
    Oncogene; 2017 Apr; 36(15):2095-2104. PubMed ID: 27721403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-κB-Mediated CCL20 Reigns Dominantly in CXCR2-Driven Ovarian Cancer Progression.
    Ignacio RM; Kabir SM; Lee ES; Adunyah SE; Son DS
    PLoS One; 2016; 11(10):e0164189. PubMed ID: 27723802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade.
    Yung MM; Tang HW; Cai PC; Leung TH; Ngu SF; Chan KK; Xu D; Yang H; Ngan HY; Chan DW
    Theranostics; 2018; 8(5):1270-1285. PubMed ID: 29507619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of EGR-1 modulates the activity of NF-κB and AP-1 in prostate carcinoma PC-3 and LNCaP cell lines.
    Parra E; Ferreira J; Ortega A
    Int J Oncol; 2011 Aug; 39(2):345-52. PubMed ID: 21617851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin suppresses interleukin 1beta-mediated microsomal prostaglandin E synthase 1 by altering early growth response gene 1 and other signaling pathways.
    Moon Y; Glasgow WC; Eling TE
    J Pharmacol Exp Ther; 2005 Nov; 315(2):788-95. PubMed ID: 16081677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-23 promotes growth and proliferation in human squamous cell carcinoma of the oral cavity.
    Fukuda M; Ehara M; Suzuki S; Ohmori Y; Sakashita H
    Int J Oncol; 2010 Jun; 36(6):1355-65. PubMed ID: 20428758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.